Research-stage peptides
Research-stage profiles summarize available evidence and are not treatment recommendations. These compounds are not FDA-approved for human use; some are prescription-only or compounding-only.
These 75 peptides are studied primarily in laboratory, preclinical, or early clinical settings, or are handled through compounding rather than FDA approval. Evidence quality varies widely — each profile carries an evidence grade and a regulatory status so you can tell validated clinical evidence from preliminary research. For approved drugs, see the FDA-approved list, or FDA-approved vs research-only for how the two compare.
A
Myostatin inhibitor
Hypoxic pain and healing
Metabolic immune support
Fat loss, metabolic enhancement
Neuropathic pain specialist
Botox-like peptide
B
Immune activating complex
Healing & recovery, gut health
C
Combination therapy
Neuroprotection, recovery
Growth hormone, muscle mass, fat loss
Structural bone and joint support
Brain bioregulator
Neuropeptide complex
D
Hormone precursor support
Potent cognitive enhancer
Delta sleep-inducing peptide
E
Longevity, telomere support
Anti-aging performance combo
F
NCAM mimetic
HGH fragment for fat loss
G
Wound healing, skin regeneration
Appetite and healing support
Fourth generation GHRP
Trending injectable research blend of GHK-Cu, BPC-157 and TB-500, marketed for skin rejuvenation and tissue recovery. Not FDA-approved; sold as a research chemical.
Sleep quality amino peptide
Antiviral immune booster
H
Testosterone production support
Cell renewal peptide
Potent GH releaser
Mitochondrial protection, longevity
I
Russian immune peptide
GH secretagogue, anti-aging
K
Reproductive hormone regulator
Anti-inflammatory immune peptide
L
Gut permeability regulator
Satiety hormone
Antimicrobial defense peptide
M
Anti-aging skincare
Advanced collagen booster
Tanning, libido
Enhanced melatonin delivery
NMDA antagonist
Oral GH secretagogue
Mitochondrial optimization
N
Triple modified Semax
Neurogenesis, depression
O
Digestive system bioregulator
P
Neurogenic peptide
Collagen booster
Natural pain modulator
Joint and bladder support
Pineal gland bioregulator
Prostate and male hormone support
R
Investigational triple agonist (GIP/GLP-1/glucagon). TRIUMPH-1 Phase 3 (May 2026): 28.3% body weight loss at 80 weeks. FDA submission anticipated Q3–Q4 2026.
Adaptogenic peptide
S
Anxiety reduction, focus
Extended release Selank
Cognitive enhancement, focus, memory
Evening cognitive calming
Extended release Semax
Enhanced Argireline
Spleen-derived immune peptide
Mitochondrial optimization
Collagen synthesis peptide
T
Tissue repair, flexibility, inflammation
TB-500 fragment
Thymus restoration peptide
Immune system support
Comprehensive tissue pain relief
Thyroid function support
U
Mitochondrial health compound
V
Simple immune dipeptide
Thymus bioregulator complex
Y
Myostatin inhibitor